Not yet recruiting NCT06958146
Azithromycin for Preventing Maternal and Neonatal Infections During Labor.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: oral azithromycin, no azithromycin.
- Who it may be relevant to
- Registry conditions: Maternal and Neonatal Sepsis, Intrapartum Antibiotics. Basic parameters: 18 years — 45 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Impact of Single Dose Azithromycin During Labor on Maternal and Neonatal Infections
Overview
In this study, we want to see the role of the antibiotic, azithromycin, in preventing maternal and neonatal infections, if the drug is given intrapartum to the mother
Interventions
- Drug oral azithromycin
we will be administering single-dose oral azithromycin to ladies who go into labor and have no risk factors for sepsis, as there is increased risk of postpartum sepsis in both mother and neonate after normal vaginal delivery in low-income and middle-income countries - Other no azithromycin
participants in this arm will be given only standard labor care and no oral azithromycin
Primary outcome measures
- maternal infections [Time frame: birth to 6 weeks post partum]
Secondary outcome measures (1)
- neonatal infections [Time frame: birth to 6 weeks post partum]
Eligibility criteria
Inclusion criteria
- pregnant ladies with no risk factors for sepsis who go into spontaneous labor or induced labor
Exclusion criteria
- pregnant with risk factors for sepsis like maternal fever , raised WBC count, chorioamnionitis, or having. history of any adverse even with macrolides
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06958146 · Azithromycin 2025